首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 1期肝纤维化及肝硬化 => 肝脏肿瘤 =>微波凝固坏死疗法联合腹腔镜脾切除术治疗原..
微波凝固坏死疗法联合腹腔镜脾切除术治疗原发性肝癌合并脾功能亢进的效果观察
Clinical effect on microwave coagulo-necrotic therapy combined with laparoscopic splenectomy in treatment of primary hepatocellular carcinoma complicated by hypersplenism
文章发布日期:2017年12月09日  来源:  作者:刘曙民,孙邱,张美菊  点击次数:80次  下载次数:10次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:目的 探讨微波凝固坏死疗法(MCN)和腹腔镜脾切除术(LS)联合治疗原发性肝癌(PHC)合并脾功能亢进患者的可行性及安全性。方法 回顾性分析2008年1月-2012年12月宝鸡市人民医院收治的MCN和LS联合治疗的PHC合并脾功能亢进患者22例。收集患者临床资料,观察患者术后并发症及生存情况。计量资料比较采用t检验,累积生存曲线采用Kaplan-Meier法绘制。结果 MCN治疗中5例经胸廓切开术、15例经剖腹术、2例经腹腔镜术,LS治疗中17例采用手辅助LS、5例行单纯LS。平均手术时间(303.24±56.02) min,平均失血量(146.92±60.72)ml,平均切除脾脏重量(670.42±204.54)g。22例患者术后6例(27.27%)发病、5例(22.73%)门静脉血栓形成、2例(9.09%)存在胸腔积液。术后1个月血小板计数较术前显著升高[(15.72±5.47)×104/μl vs (4.43±1.03)×104/μl, t=6.83, P<0.001]。术后1、3、5年总生存率分别为90.91%、68.18%、59.09%,术后1、3、5年无病生存率分别为59.09%、13.64%、13.64%。结论 MCN和LS联合治疗PHC合并脾功能亢进患者安全、有效、可行。
【Abstract】:Objective o investigate the feasibility and safety of microwave coagulo-necrotic therapy (MCN) combined with laparoscopic splenectomy (LS) in the treatment of primary hepatocellular carcinoma (PHC) complicated by hypersplenism. Methods A retrospective analysis was performed for the clinical data of 22 PHC patients with hypersplenism who were admitted to Baoji Municipal People′s Hospital from January 2008 to December 2012 and underwent MCN combined with LS. Their clinical data were collected, and postoperative complications and survival were observed. The t-test was used for comparison of continuous data, and the Kaplan-Meier method was used to plot cumulative survival curves. Results In MCN therapy, 5 patients underwent thoracotomy, 15 underwent laparotomy, and 2 underwent laparoscopic surgery; in LS treatment, 17 underwent hand-assisted LS and 5 underwent simple LS. The mean time of operation was (303.24±56.02) min, the mean blood loss volume was (146.92±60.72) ml, and the mean weight of the resected spleen was (670.42±204.54) g. Of all patients, 6 (27.27%) experienced postoperative recurrence, 5 (22.73%) experienced portal vein thrombosis, and 2 (9.09%) experienced pleural effusion. There was a significant increase in platelet count at 1 month after surgery [(15.72±5.47)×104/μl vs (4.43±1.03)×104/μl, t=6.83, P<0.001]. The 1-, 3-, and 5-year overall survival rates after surgery were 90.91%, 68.18%, and 59.09%, respectively, and the 1-, 3-, and 5-year disease-free survival rates were 59.09%, 13.64%, and 13.64%, respectively. Conclusion MCN combined with LS is safe, effective, and feasible in the treatment of PHC complicated by hypersplenism.
【关键字】:肝肿瘤;脾功能亢进;导管消融术;脾切除术;治疗结果
【Key words】:liver neoplasms; hypersplenism; catheter ablation; splenectomy; treatment outcome
【引证本文】:LIU SM, SUN Q, ZHANG MJ. Clinical effect on microwave coagulo-necrotic therapy combined with laparoscopic splenectomy in treatment of primary hepatocellular carcinoma complicated by hypersplenism[J]. J Clin Hepatol, 2018, 34(1): 142-146. (in Chinese)
刘曙民, 孙邱, 张美菊. 微波凝固坏死疗法联合腹腔镜脾切除术治疗原发性肝癌合并脾功能亢进的效果观察[J]. 临床肝胆病杂志, 2018, 34(1): 142-146.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号